tradingkey.logo

Charles River Laboratories International Inc

CRL

152.240USD

-0.650-0.43%
收盤 09/15, 16:00美東報價延遲15分鐘
7.49B總市值
虧損本益比TTM

Charles River Laboratories International Inc

152.240

-0.650-0.43%
關於 Charles River Laboratories International Inc 公司
Charles River Laboratories International, Inc. 提供基本產品和服務,幫助全球製藥和生物技術公司、政府機構和學術機構加速其研究和藥物開發工作。該公司的研究模型和服務部門由三項業務組成,提供基礎工具,使其客戶能夠發現新分子:研究模型、研究模型服務和細胞解決方案。其發現和安全評估部門提供受監管和非受監管的 DSA 服務,以支持潛在新藥的研究、開發和監管要求的安全測試,包括治療發現和優化以及體外和體內研究、實驗室支持服務以及戰略非臨牀諮詢和項目管理,以支持產品開發。其製造解決方案部門包括微生物解決方案和生物製劑解決方案。
公司簡介
公司代碼CRL
公司名稱Charles River Laboratories International Inc
上市日期Jun 23, 2000
CEOMr James C. Foster
員工數量18600
證券類型Ordinary Share
年結日Jun 23
公司地址251 Ballardvale St
城市WILMINGTON
上市交易所NYSE Consolidated
國家United States of America
郵編01887
電話17812226000
網址https://www.criver.com/
公司代碼CRL
上市日期Jun 23, 2000
CEOMr James C. Foster
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr James C. Foster
Mr James C. Foster
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
267.96K
+6.88%
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Chief Operating Officer, Corporate Executive Vice President
57.72K
+24.38%
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
17.89K
+48.67%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment Management
Corporate Executive Vice President - Discovery and Safety Assessment Management
12.88K
+69.56%
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
12.48K
-8.77%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
4.91K
+23.86%
Dr. Nancy C. Andrews, M.D., Ph.D.
Dr. Nancy C. Andrews, M.D., Ph.D.
Independent Director
Independent Director
3.96K
+31.35%
Ms. Reshema Kemps-Polanco
Ms. Reshema Kemps-Polanco
Independent Director
Independent Director
2.59K
+155.42%
Dr. Craig B. Thompson, M.D.
Dr. Craig B. Thompson, M.D.
Independent Director
Independent Director
2.41K
+64.49%
Mr. Abraham N. (Abe) Ceesay
Mr. Abraham N. (Abe) Ceesay
Independent Director
Independent Director
946.00
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr James C. Foster
Mr James C. Foster
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
267.96K
+6.88%
Ms. Birgit Girshick
Ms. Birgit Girshick
Chief Operating Officer, Corporate Executive Vice President
Chief Operating Officer, Corporate Executive Vice President
57.72K
+24.38%
Ms. Victoria L. (Vicky) Creamer
Ms. Victoria L. (Vicky) Creamer
Corporate Executive Vice President, Chief People Officer
Corporate Executive Vice President, Chief People Officer
17.89K
+48.67%
Ms. Shannon M. Parisotto
Ms. Shannon M. Parisotto
Corporate Executive Vice President - Discovery and Safety Assessment Management
Corporate Executive Vice President - Discovery and Safety Assessment Management
12.88K
+69.56%
Mr. Joseph W. LaPlume
Mr. Joseph W. LaPlume
Corporate Executive Vice President - Corporate Development and Strategy
Corporate Executive Vice President - Corporate Development and Strategy
12.48K
-8.77%
Ms. Virginia M. (Gina) Wilson, CPA
Ms. Virginia M. (Gina) Wilson, CPA
Independent Director
Independent Director
4.91K
+23.86%
收入明細
單位: USD更新時間: 7月6日 週日
單位: USD更新時間: 7月6日 週日
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
業務USD
名稱
營收
佔比
DSA
592.61M
60.21%
RMS
213.07M
21.65%
Manufacturing
178.49M
18.14%
地區USD
名稱
營收
佔比
United States
536.96M
54.56%
Europe
263.25M
26.75%
Canada
125.35M
12.74%
Asia Pacific (Region)
41.94M
4.26%
Other
16.67M
1.69%
業務
地區
業務USD
名稱
營收
佔比
DSA
592.61M
60.21%
RMS
213.07M
21.65%
Manufacturing
178.49M
18.14%
股東統計
更新時間: 8月19日 週二
更新時間: 8月19日 週二
持股股東
股東類型
持股股東
持股股東
佔比
The Vanguard Group, Inc.
11.79%
Wellington Management Company, LLP
7.66%
BlackRock Institutional Trust Company, N.A.
5.59%
Allspring Global Investments, LLC
4.66%
State Street Global Advisors (US)
3.78%
其他
66.54%
持股股東
持股股東
佔比
The Vanguard Group, Inc.
11.79%
Wellington Management Company, LLP
7.66%
BlackRock Institutional Trust Company, N.A.
5.59%
Allspring Global Investments, LLC
4.66%
State Street Global Advisors (US)
3.78%
其他
66.54%
股東類型
持股股東
佔比
Investment Advisor
44.29%
Investment Advisor/Hedge Fund
41.00%
Hedge Fund
9.40%
Research Firm
5.94%
Bank and Trust
2.19%
Pension Fund
1.49%
Individual Investor
1.05%
Sovereign Wealth Fund
1.04%
Private Equity
0.20%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
1399
56.14M
114.06%
-4.38M
2025Q1
1435
55.38M
112.72%
-5.93M
2024Q4
1423
54.85M
107.26%
-4.35M
2024Q3
1392
53.78M
105.14%
-5.12M
2024Q2
1399
54.00M
104.84%
-4.00M
2024Q1
1393
53.76M
104.37%
-4.04M
2023Q4
1424
53.56M
104.42%
-4.24M
2023Q3
1446
53.56M
104.42%
-3.98M
2023Q2
1427
52.88M
103.32%
-3.95M
2023Q1
1431
52.72M
103.01%
-2.79M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
The Vanguard Group, Inc.
6.09M
12.41%
-39.84K
-0.65%
Mar 31, 2025
Wellington Management Company, LLP
4.29M
8.72%
+208.59K
+5.12%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.91M
5.92%
-42.75K
-1.45%
Mar 31, 2025
Allspring Global Investments, LLC
1.77M
3.61%
-33.40K
-1.85%
Mar 31, 2025
State Street Global Advisors (US)
1.90M
3.87%
-278.81K
-12.78%
Mar 31, 2025
Nomura Securities Co., Ltd.
601.62K
1.22%
+293.81K
+95.46%
Mar 31, 2025
Ariel Investments, LLC
1.10M
2.24%
+33.45K
+3.13%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.26M
2.57%
+30.45K
+2.47%
Mar 31, 2025
Invesco Capital Management LLC
981.66K
2%
+78.23K
+8.66%
Mar 31, 2025
查看更多
持股ETF
機構名稱
佔比
暫無數據
分紅派息
近5年累計派現 0.00 美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
暫無數據
公告日期
類型
比率
暫無數據
KeyAI